Ascorbate mitigates oxidative stress and hemin cytotoxicity in heme oxygenase-1 deficiency.

Berendes LS; Westhoff PS; Tobinski AM; Narvaez Pardo JA; Wingert V; Fobker M; Biskup S; Seelhöfer A; Van Marck V; Heitplatz B; Drell PT; Wittkowski H; Das AM; Hannibal L; Nowak WN; Józkowicz A; Klotz L; Varga G; Marquardt T; Park J

Abstract

Heme oxygenase-1 (HO-1) deficiency manifests with severe metabolic abnormalities, yet the underlying mechanisms remain incompletely understood. We investigated metabolic adaptations in HO-1 deficient cells using patient-derived lymphoblastoid cells (LCL) and HEK293T knockout cells. Both cell types demonstrated concurring metabolic signatures, including a substantial reduction in intracellular ascorbic acid levels despite compensatory upregulation of sodium-dependent vitamin C transporter 2 (SVCT2) and downregulation of GLUT1 compared to wild-type cells. Ultrastructural examination revealed abnormal mitochondrial morphology in both models. Both cell types showed higher baseline hydrogen peroxide levels compared to wild-type cells. Treatment with 2-phospho-L-ascorbic acid (AA2P) restored cell viability in both models upon hemin-induced stress, with protection requiring functional SVCT2-mediated uptake. AA2P supplementation attenuated the elevated H2O2 levels without altering glutathione redox homeostasis as measured by GSH/GSSG ratios. These findings illuminate ascorbic acid metabolism as a critical node in HO-1 deficiency pathophysiology and suggest ascorbic acid supplementation as a potential therapeutic strategy for this rare disorder.